KYTXKyverna Therapeutics Inc. Common Stock
8.420USD-5.07%Mkt Cap: 520.72M $P/E: —3d ago
Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap520.72M $
Enterprise Value336.36M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-161.31M $
Revenue/Share—
Last Price8.420 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees149
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.65
PEG—
EV/EBITDA-2.14
EV/Revenue—
P/S—
P/B3.02
EPS (TTM)-2.68
EPS (Forward)-3.07
52W Range
3.27050% of range13.67
52W High13.67 USD
52W Low3.270 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-69.45%
ROA-54.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-153.71M $
CapEx (TTM)1.13M $
FCF Margin—
FCF Yield-20.68%
Net Debt-166.43M $
Net Debt/EBITDA1.06
Balance Sheet
Debt/Equity0.12
Current Ratio9.06
Quick Ratio8.75
Book Value/Sh2.689 USD
Cash/Share3.225 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.40 USD
Upside (mean)+261.0%
Target Range25.00 USD – 33.00 USD
$25.00+261.0% to mean$33.00
# Analysts5
Ownership
Shares Out.61.84M
Float39.72M
Insiders6.98%
Institutions78.53%
Short Interest
Short Ratio7.3d
Short % Float15.84%
Short % Out.13.45%
Shares Short8.18M
Short (prev mo.)7.22M
Technical
SMA 508.112 (+3.8%)
SMA 2008.341 (+1.0%)
Beta1.94
S&P 52W Chg18.16%
Avg Vol (30d)923.65K
Avg Vol (10d)774.19K
Technical Indicators
RSI (14)55.5
MACD0.1547
MACD Signal0.0146
MACD Hist.+0.1401
BB Upper8.845 USD
BB Middle7.853 USD
BB Lower6.861 USD
BB Width25.25%
ATR (14)0.5290 USD
Vol Ratio (20d)0.89x